Article Details
Retrieved on: 2021-06-07 10:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Seagen's investigational monoclonal antibody targeting B-cell maturation agent (BCMA), in patients with relapsed or refractory multiple myeloma.
Article found on: www.globenewswire.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here